These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12573017

  • 1. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
    Sclimenti CR, Neviaser AS, Baba EJ, Meuse L, Kay MA, Calos MP.
    Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Site-specific genomic integration produces therapeutic Factor IX levels in mice.
    Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP.
    Nat Biotechnol; 2002 Nov; 20(11):1124-8. PubMed ID: 12379870
    [Abstract] [Full Text] [Related]

  • 5. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
    Tsukamoto H, Wells D, Brown S, Serpente P, Strong P, Drew J, Inui K, Okada S, Dickson G.
    Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
    [Abstract] [Full Text] [Related]

  • 6. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
    Peng JQ, Dong XY, Peng M, Chen L, Tan SP, Yuan H, Chen FP, Xue JL, Wu XB.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
    [Abstract] [Full Text] [Related]

  • 7. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
    Chen XG, Zhu HZ, Gong JL, Li F, Xue JL.
    Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
    [Abstract] [Full Text] [Related]

  • 8. Long-term gene expression from autonomously replicating vectors in mammalian cells.
    Wohlgemuth JG, Kang SH, Bulboaca GH, Nawotka KA, Calos MP.
    Gene Ther; 1996 Jun; 3(6):503-12. PubMed ID: 8789800
    [Abstract] [Full Text] [Related]

  • 9. Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector.
    Tsui LV, Kelly M, Zayek N, Rojas V, Ho K, Ge Y, Moskalenko M, Mondesire J, Davis J, Roey MV, Dull T, McArthur JG.
    Nat Biotechnol; 2002 Jan; 20(1):53-7. PubMed ID: 11753362
    [Abstract] [Full Text] [Related]

  • 10. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
    Mũcke S, Polack A, Pawlita M, Zehnpfennig D, Massoudi N, Bohlen H, Doerfler W, Bornkamm G, Diehl V, Wolf J.
    Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
    [Abstract] [Full Text] [Related]

  • 11. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.
    Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S.
    Nat Genet; 1998 Feb; 18(2):180-3. PubMed ID: 9462752
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
    Cachianes G, Ho C, Weber RF, Williams SR, Goeddel DV, Leung DW.
    Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H, Adebakin S, Themis M, Cook T, Douar AM, Pavirani A, Coutelle C.
    J Gene Med; 1999 Aug; 1(6):424-32. PubMed ID: 10753068
    [Abstract] [Full Text] [Related]

  • 14. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
    Hou J, Wang J, Min B.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
    [Abstract] [Full Text] [Related]

  • 15. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
    Yao SN, Smith KJ, Kurachi K.
    Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T, Ohtsuru A, Tokunaga Y, Namba H, Kaneda Y, Nagata I, Yamashita S.
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conditions affecting hydrodynamics-based gene delivery into mouse liver in vivo.
    Feng DM, He CX, Miao CY, Lu B, Wu WJ, Ding YF, Xue JL.
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):850-5. PubMed ID: 15659048
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.